In the present study, there were statistically significant differences between the groups of CASP12 mRNA with high and low expression in terms of differentiation, lymph node metastasis, tumor size, FIGO staging and clinical outcomes. The gene discussed is CASP12; the disease is metastatic malignant neoplasm in the lymph nodes.